Elicera Therapeutics Receives Chinese Notice of Allowance for ELC-401 Patent
Elicera Therapeutics AB says it received a China National Intellectual Property Administration notice of allowance for its ELC-401 patent.
Elicera Therapeutics AB says it received a China National Intellectual Property Administration notice of allowance for its ELC-401 patent.